CompletedNot Applicable

Fetal Cardiac Function

Egypt72 participantsStarted 2024-04-30

Plain-language summary

The aim of our study is to evaluate the effect of PE and FGR on fetal cardiac function. Pregnancies with preeclampsia and FGR, and preeclampsia with normal fetal growth are evaluated by echocardiography and compared with uncomplicated pregnancies.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Pregnant women more than or equals 28 weeks * Preeclampsia defined as systolic blood pressure 140 mm Hg and/or diastolic blood pressure 90 mm Hg * Fetus with normal growth or with growth restriction Exclusion criteria: * congenital malformations * intrauterine infection * multiple pregnancies * fetuses of mothers treated with a tocolytic agent * fetuses with abnormal heart rates (tachycardia or bradycardia)

What they're measuring

Cardiac systolic function

Timeframe: 4 months

Trial details

NCT IDNCT06381258

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-01

View on ClinicalTrials.gov More Fetal Growth Retardation trials